Page 5 - Harshita Singh

Stocks to Watch: MCX, TCS, Reliance, Bank of Baroda, Titan, Liquor, sugar

Stocks to Watch on October 9, 2023: MCX has received approval from Sebi's technical advisory panel to shift to the new commodity derivative trading platform

Analysts selective on sugar stocks as higher prices keeps outlook upbeat

Analysts expect lower output to keep sugar prices elevated at least for the next year, driving gains for the sector

Accenture guidance delays hopes of demand pick-up for Indian IT: Analysts

Nirmal Bang analysts suggest investors use the gains to pare positions if overweight, especially in the tier-2 IT pack

Analysts bet on these consumption pockets ahead of the festive season

Fast-moving consumer goods (FMCG), retail, and consumer electronics segments are expected to do well over the next few months

Nykaa, Paytm, Zomato: Canadian FPI-held stocks take a hit on widening rift

Stocks held by Canada Pension Plan Investment Board (CPPIB), which is among the biggest FPIs investing in the domestic market, have come under pressure since developments on the India-Canada tensions

Cipla on the block: Who's a better fit and what it means for shareholders?

As per IIFL Securities, Cipla with a dominating market share of 7% and 23% in acute therapies like respiratory and anti-infectives, respectively, would strengthen Torrent's position in these

Rising crude, uncertainty ahead of elections keep analysts wary on OMCs

Analysts say the already weakening marketing margins will be a concern ahead as the fate of OMCs remains tied to uncertain crude prices and the inability to raise prices amid the coming elections

RIL 46th AGM: Brokerages insipid but keep positive ratings on stock intact

Reliance 46th AGM: The stock would see a significant upside only on listing timelines of the retail and telecom businesses, first announced four years ago in 2019, analysts said

LT Foods, KRBL, Chaman Lal, GRM slide up to 6% on basmati rice export curbs

KRBL, GRM Overseas and Chaman Lal Setia, meanwhile, dropped over 3 per cent, 4 per cent and 6 per cent, respectively, to their respective intra-day lows

Are equity markets pricing in rupee weakness and related risks?

Analysts say equity markets will begin baking in the negatives and weakness in the rupee if the US Fed chief Jerome Powell delivers a hawkish commentary at Jackson Hole later this week

Stocks to Watch: Torrent Pharma, Cipla, TVS Supply Chain, Titan, AdaniTotal

Stocks to Watch on August 23, 2023: Torrent Pharma has joined the race to buy out Cipla's promoter stake held by the Hamied family, reported The Economic Times

Stocks to Watch: Jio Financial, Titan, Gujarat Gas, Tanla Platforms, KEC

Stocks to Watch on August 21, 2023: Jio Financial Services will be listed on the exchanges today. Experts believe the stock could top the Rs 300-mark on listing

Defence stocks pricing in all positives and offer limited upside: Analysts

However, the rally, which has been accompanied by high valuations, could stagnate in near term as companies may not meet investors' expectations of sustained performance every quarter, analysts say

Laptop import curbs lift EMS stocks but analysts warn of jumping the gun

In the June quarter, electronics became India's fourth-largest exported item overtaking chemicals, drugs and pharmaceuticals. This surge was led by mobile phones aided by 2020 PLI scheme

Jhunjhunwala-backed Concord Biotech IPO opens today: What do analysts say?

Concord Biotech IPO: The stock is commanding a 20 per cent premium in the grey market, as per ipowatch.com

Dixon Tech, Optiemus, HCL Info rally 8-9% on laptops, tablets import curbs

Dixon Technologies surged 8 per cent to its intra-day high of Rs 4,467 apiece. HCL Infosystems rallied 9 per cent to a high of Rs 17.40 and Optiemus Infracom jumped 8 per cent

Sun Pharma Q1 net profit drops 2% YoY, Revenue up 11%; US sales at $471 mn

Sun Pharma Q1 results: The net profit was reported after accounting for an exceptional loss of Rs 323 crore. EBITDA margin for Q1 came at 27.9 per cent over 26.8 per cent reported in Q1FY23

Sun Pharma Q1 profit may be weighed by weak US generic sales and Taro nos

Sun Pharma Q1 results: The company's Q1 net profit could dip fractionally by 0.15 per cent to Rs 2,058 crore against Rs 2,061 crore reported a year ago

BSE SmallCap index hits fresh high; eyes 35,000 after surging 28% in FY24

Around 40 stocks on the BSE SmallCap index scaled new record highs, including The Anup Engineering, Bector Food, Cholamandalam Fin, CMS Info, CreditAccess Grameen, RPG Life, Escorts, Inox Green

Should you subscribe to Yatharth Hospital's IPO? Here's what brokerages say

Yatharth Hospital IPO: In the grey market, the hospital chain's share is commanding a 20 per cent premium over its upper price band of Rs 300